ArticleMolecular therapy oncolytics2023

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.

Firas Hamdan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.